维普期刊资源整合服务平台（V6.5）

46篇 您的检索式：作者名="EBETINO FH"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis显示文摘	Pazianas M Cooper C Ebetino FH	2010	Ther Clin Risk Manag2010，6，：	1
2	Bisphosphonates:molecular mechanisms of action and effects on bone cells,monocytes and macrophages显示文摘	Roelofs AJ Thompson K Ebetino FH	2010	Curr Pharm Des2010，16，27：	1
3	Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis显示文摘	Pazianas M Cooper C Ebetino FH	2010	Ther Clin Risk Manag2010，6，1：	1
4	Bisphosphonates:mol- ecular mechanisms of action and effects on bone cells,monocytes and macrophages显示文摘	Roelofs AJ Thompson K Ebetino FH	2010	Curr Pharm Des2010，16，27：	1
5	Bisphos- phonate bone affinity as assessed by inhibition of carbonated apatite dissolution in vitro显示文摘	Henneman ZJ Nancollas GH Ebetino FH	2008	J Biomed Mater Res A2008，85，4：	1
6	Bisphosphonates:molecular mechanisms of action and effects on bone cells,monocytes and macrophages显示文摘	Roelofs AJ Thompson K Ebetino FH	2010	Curr Pharm Des2010，16，27：	1
7	Mechanisms of action of bisphosphonates: Similarities and differences and their potential influence on clinical efficacy显示文摘	Russell RG Watts NB Ebetino FH	2008	Os- teoporos Int2008，19，6：	1
8	Long - term treatment with bisphosphonates and their safety in postmenopausal osteoporosis 显示文摘	Pazianas M Cooper C Ebetino FH	2010	Ther Clin Risk Manag2010，6，：	1
9	J Bisphosphonates and cancer-induced bone disease: bevond their antiresorptive activity 显示文摘	Clezardin P Ebetino FH Fournier PG	2005	Cancer Res2005，65，12：	1
10	Bisphosphonates:Structure-activity relationships and therapeutic implications显示文摘	Geddes AD D'Souza SM Ebetino FH	1994	Bone Miner Res1994，8，：	1
11	Bisphosphonates and cancer-induced bone disease: Beyond their antiresorptive activity 显示文摘	Clezardin P Ebetino FH Foumier PG	2005	Cancer Res2005，65，12：	1
12	Meehanisms of action of bisphosphonates : similarities and differences and their potential influence on clinical efficacy显示文摘	RUSSELL RG WATTS NB EBETINO FH	2008	Osteoporos lnt2008，19，6：	1
13	Bisphos- phonate binding affinity as assessed by inhibition of car- bonated apatite dissolution in vitro 显示文摘	Henneman ZJ Nancollas GH Ebetino FH	2008	J Biomed Mater Res A2008，85，4：	1
14	Biomarkers of bone health and osteoporosis risk 显示文摘	RUSSELL RG WATTS NB EBETINO FH	2008	Proc Nutr Soc2008，67，2：	1
15	Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy 显示文摘	Russell RG Watts NB Ebetino FH	2008	Os- teoporos Int2008，19，：	1
16	Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages显示文摘	Roelofs AJ Thompson K Ebetino FH	2010	Curr Pharm Des2010，16，27：	1
17	Mechanisms of action of Etidronate and other bisphosphonates显示文摘		1998	Rev Gontemp Pharma1998，9，：	1
18	Etidronate mechanism of action of etidronate and other bisphosphonates显示文摘	Ebetino FH Francis MD Rogers MJ	1998	Rev Contemp Pharmacol1998，9，5：	1
19	Effect of risedronate on osteocyte viability and bone turnover in paired iliac bone biopsies from early postmenopausal women显示文摘	Qiu S Phipps RJ Ebetino FH		0，，05：	1
20	The relationship between the chemistry and biological activity of the bisphosphonates 显示文摘	Ebetino FH Hogan AM Sun S	2011	Bone2011，49，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示